Tvardi Therapeutics, Inc. - TVRD

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$10.4M
QoQ value delta ($000)
-$1.779M (-14.6%)
Implied price effect (QoQ)
-22.28%
Shares
Total shares
3,128,110
QoQ shares delta
+281,249 (+9.88%)
Total shares held by funds (by quarter)

Market chart (TVRD)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 67 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Slate Path Capital LP 2,239 704,118 0.03%
VANGUARD GROUP INC 1,826 424,821 0.0%
BlackRock, Inc. 1,234 388,075 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 1,096 344,708 0.0%
AMERICAN FINANCIAL GROUP INC 711 223,659 0.26%
GEODE CAPITAL MANAGEMENT, LLC 579 182,339 0.0%
SILVERCREST ASSET MANAGEMENT GROUP LLC 321 101,034 0.0%
STATE STREET CORP 309 97,231 0.0%
RENAISSANCE TECHNOLOGIES LLC 292 92,100 0.0%
MORGAN STANLEY 231 72,894 0.0%
Duncan Williams Asset Management, LLC 201 63,241 0.06%
UBS Group AG 160 50,454 0.0%
NORTHERN TRUST CORP 156 49,081 0.0%
VANGUARD FIDUCIARY TRUST CO 149 46,872 0.0%
AQR CAPITAL MANAGEMENT LLC 134 42,192 0.0%
GREAT LAKES ADVISORS, LLC 115 36,236 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 107 33,833 0.0%
Squarepoint Ops LLC 103 32,676 0.0%
GOLDMAN SACHS GROUP INC 75 23,898 0.0%
Russell Investments Group, Ltd. 74 23,307 0.0%
FARALLON CAPITAL MANAGEMENT LLC 68 21,438 0.0%
Bank of New York Mellon Corp 55 17,405 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 37 11,784 0.0%
Arax Advisory Partners 26 8,333 0.0%
FMR LLC 16 5,278 0.0%